← Eichor
Condition: Human Papillomavirus Infection Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Human Papillomavirus Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts
Phase 2 · 1 location(s) · Zagazig University · NCT05291845Normalizing Antibody Detection in First-void Urine
Phase N/A · 1 location(s) · Universiteit Antwerpen · NCT06582654Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After H
Phase 2 · 3 location(s) · Universiteit Antwerpen · NCT07407569Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910Lot-to-Lot Consistency Clinical Trial of Recombinant Human Papillomavirus 9-valent (Types 6/11/16/18/31/33/45/52/58) Vac
Phase 4 · 1 location(s) · Xiamen Innovax Biotech Co., Ltd · NCT07668271Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel
Phase 2 · 1 location(s) · KTH Biopharma · NCT07698886Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India
NA · 3 location(s) · University of California, Irvine · NCT07209917PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia
Phase 2 · 10 location(s) · PapiVax Biotech, Inc. · NCT07454915Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05026138Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-esca
Phase 2 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT07209189Study of 2LPAPI® on the Clearance of Genital HR-HPV Infections.
Phase 4 · 12 location(s) · Labo'Life · NCT04232917Digital Telecytology for Triage of HPV-Positive Women in Cameroon
NA · 2 location(s) · University Hospital, Geneva · NCT07550010Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus
Phase N/A · 1 location(s) · Regina Elena Cancer Institute · NCT05918510A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Wome
Phase 3 · 8 location(s) · National Vaccine and Serum Institute, China · NCT05262010Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Phase 3 · 1 location(s) · Shanghai Bovax Biotechnology Co., Ltd. · NCT04422366Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytolo
Phase 2 · 1 location(s) · Amplexd Therapeutics, Inc. · NCT07572396Effect of Different HPV Education Methods on Vaccination Intention in Young Women
NA · 1 location(s) · Emel GÜÇLÜ CİHAN · NCT07420556Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve
NA · 1 location(s) · The University of Texas Health Science Center, Houston · NCT06598475Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts
Phase 2/Phase 3 · 2 location(s) · Western Institute for Veterans Research · NCT05625633People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity
Phase N/A · 1 location(s) · University of California, San Francisco · NCT06055868Prevalence and Clinical Implications of HPV Infection in Male IBD Patients
Phase N/A · 1 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT05911750Point of Care - Triage and Treatment for Cervical Pre-cancer
NA · 1 location(s) · Basic Health International, Inc. · NCT07461818Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)
Phase 3 · 6 location(s) · Verrica Pharmaceuticals Inc. · NCT07246590HUC-MSC for Treatment of High-risk HPV Infection
Phase 1/Phase 2 · 1 location(s) · Shanghai East Hospital · NCT06610773Zopa Retreatment and Vector Shedding in Adults With RRP
Phase 4 · 3 location(s) · Precigen, Inc · NCT06538480A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women A
Phase 4 · 1 location(s) · Miquel Angel Pavon Ribas · NCT05334706Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine
Phase N/A · 2 location(s) · Shanghai Bovax Biotechnology Co., Ltd. · NCT05371353Assessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique
NA · 1 location(s) · Instituto Nacional de Saúde, Mozambique · NCT06326294Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring
Phase N/A · 1 location(s) · The Institute of Molecular and Translational Medicine, Czech · NCT05774561The Women's Screening and Self-Testing Program (PROMETA) Study
NA · 1 location(s) · Tulane University · NCT06810739
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.